Prevalence of Testing for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus among Medicaid Enrollees Treated with Medications for Opioid Use Disorder in 11 States, 2016–2019

Limited information exists about testing for human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) among Medicaid enrollees after starting medication for opioid use disorder (MOUD), despite guidelines recommending such testing. The objectives of this cross-sectional study are to estimate testing prevalence and trends for HIV, HBV, and HCV among Medicaid enrollees initiating MOUD and examine enrollee characteristics associated with testing.

Senior Policy Analyst Shamis Mohamoud co-authored this article published in Clinical Infectious Diseases.